cholic acid has been researched along with Disease Exacerbation in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Chun, HJ; Kwon, YH; Shim, YJ | 1 |
| Kawaguchi, H; Komohara, Y; Nakagawa, T; Tanimoto, A; Yamada, S; Yoshii, D | 1 |
| Boehme, S; Chiang, JYL; Ferrell, JM; Gilliland, T; Pathak, P | 1 |
| Bull, LN; Elias, MS; Emerick, KM; Green, RM; Knisely, As; Melin-Aldana, H; Strautnieks, S; Thompson, RJ; Whitington, PF | 1 |
| Aranha, MM; Camilo, ME; Cortez-Pinto, H; Costa, A; da Silva, IB; de Moura, MC; Rodrigues, CM | 1 |
| Everson, GT; Marsano, L; McKinley, C; Showalter, R; Shrestha, R; Vivian, B; Wilner, K | 1 |
| Ito, H; Kawasaki, H; Noguchi, N; Oyama, K; Shiota, G; Takano, T | 1 |
7 other study(ies) available for cholic acid and Disease Exacerbation
| Article | Year |
|---|---|
Cholic acid supplementation accelerates the progression of nonalcoholic fatty liver disease to the procarcinogenic state in mice fed a high-fat and high-cholesterol diet.
Topics: Amino Acids; Animals; Carcinogenesis; Carcinoma, Hepatocellular; Cholesterol; Cholesterol, Dietary; Cholic Acid; Diet, High-Fat; Dietary Supplements; Diethylnitrosamine; Disease Progression; Gene Expression Regulation; Lipid Metabolism; Liver; Male; Metabolic Networks and Pathways; Mice; Mice, Inbred C57BL; Mitochondria, Liver; Non-alcoholic Fatty Liver Disease; Transcriptome | 2022 |
Phenotypic Changes in Macrophage Activation in a Model of Nonalcoholic Fatty Liver Disease using Microminipigs.
Topics: Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Cholesterol; Cholic Acid; Diet, High-Fat; Disease Models, Animal; Disease Progression; Hepatic Stellate Cells; Lymphocytes; Macrophage Activation; Macrophages; Non-alcoholic Fatty Liver Disease; Phenotype; Receptors, Cell Surface; Swine; Swine, Miniature | 2021 |
Deficiency of Both Farnesoid X Receptor and Takeda G Protein-Coupled Receptor 5 Exacerbated Liver Fibrosis in Mice.
Topics: Animals; Bile Acids and Salts; Biopsy, Needle; Cholesterol 7-alpha-Hydroxylase; Cholic Acid; Diet, Western; Disease Models, Animal; Disease Progression; Fatty Liver; Gene Expression Regulation; Immunohistochemistry; Liver Cirrhosis; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Oxidative Stress; Random Allocation; Receptors, Cytoplasmic and Nuclear; Receptors, G-Protein-Coupled; Signal Transduction | 2019 |
Bile composition in Alagille Syndrome and PFIC patients having Partial External Biliary Diversion.
Topics: Adolescent; Alagille Syndrome; Bile; Bile Ducts, Intrahepatic; Biopsy; Chenodeoxycholic Acid; Child; Child, Preschool; Cholestasis, Intrahepatic; Cholesterol; Cholic Acid; Digestive System Surgical Procedures; Disease Progression; Gallbladder; Humans; Infant; Lipid Metabolism; Liver; Phospholipids; Treatment Outcome | 2008 |
Bile acid levels are increased in the liver of patients with steatohepatitis.
Topics: Adult; Bile Acids and Salts; Biopsy; Chenodeoxycholic Acid; Cholic Acid; Chromatography, Gas; Deoxycholic Acid; Disease Progression; Fatty Liver; Fatty Liver, Alcoholic; Female; Humans; Liver; Male; Middle Aged; Severity of Illness Index | 2008 |
Quantitative liver function tests define the functional severity of liver disease in early-stage cirrhosis.
Topics: Administration, Oral; Adult; Aged; Antipyrine; Caffeine; Cholic Acid; Cholic Acids; Disease Progression; Female; Humans; Injections, Intravenous; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged; Prognosis | 1997 |
Oral administration of cholic acid promotes growth of liver tumors initiated by diethylnitrosamine in rats.
Topics: Administration, Oral; Animals; Apoptosis; Carcinogens; Cell Division; Cholic Acid; Diethylnitrosamine; Disease Progression; Immunohistochemistry; In Situ Nick-End Labeling; Liver Neoplasms, Experimental; Male; Rats; Rats, Inbred F344 | 1999 |